NCT03662321 - Clinical Trial References

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Citation(s)

Braun-Courville DK, Rojas M
Exposure to sexually explicit Web sites and adolescent sexual attitudes and behaviors. J Adolesc Health. 2009 Aug;45(2):156-62. doi: 10.1016/j.jadohealth.2008.12.004. Epub 2009 Feb 20.
Rice E, Gibbs J, Winetrobe H, Rhoades H, Plant A, Montoya J, Kordic T
Sexting and sexual behavior among middle school students. Pediatrics. 2014 Jul;134(1):e21-8. doi: 10.1542/peds.2013-2991.
Strassberg DS, Cann D, Velarde V
Sexting by High School Students. Arch Sex Behav. 2017 Aug;46(6):1667-1672. doi: 10.1007/s10508-016-0926-9. Epub 2017 Jan 3.
Strassberg DS, McKinnon RK, Sustaíta MA, Rullo J
Sexting by high school students: an exploratory and descriptive study. Arch Sex Behav. 2013 Jan;42(1):15-21. doi: 10.1007/s10508-012-9969-8. Epub 2012 Jun 7.
Temple JR, Paul JA, van den Berg P, Le VD, McElhany A, Temple BW
Teen sexting and its association with sexual behaviors. Arch Pediatr Adolesc Med. 2012 Sep;166(9):828-33. doi: 10.1001/archpediatrics.2012.835.

Prevalence and Vulnerability Factors of Active Cybersexuality Among Teenagers (15 - 17 Olds) in West Normandy.

Clinical trial NCT03662321 - References